Claudel T - Search Results

1

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.

Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B. Claudel T, et al. Gastroenterology. 2003 Aug;125(2):544-55. doi: 10.1016/s0016-5085(03)00896-5. Gastroenterology. 2003. PMID: 12891557

2

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

Claudel T, Leibowitz MD, Fiévet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, Heyman RA, Auwerx J. Claudel T, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2610-5. doi: 10.1073/pnas.041609298. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226287 Free PMC article.

3

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, Staels B. Claudel T, et al. J Clin Invest. 2002 Apr;109(7):961-71. doi: 10.1172/JCI14505. J Clin Invest. 2002. PMID: 11927623 Free PMC article.

4

Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.

Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Pineda Torra I, et al. Among authors: claudel t. Mol Endocrinol. 2003 Feb;17(2):259-72. doi: 10.1210/me.2002-0120. Mol Endocrinol. 2003. PMID: 12554753

5

FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.

Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B. Barbier O, et al. Among authors: claudel t. Gastroenterology. 2003 Jun;124(7):1926-40. doi: 10.1016/s0016-5085(03)00388-3. Gastroenterology. 2003. PMID: 12806625

6

The farnesoid X receptor induces very low density lipoprotein receptor gene expression.

Sirvent A, Claudel T, Martin G, Brozek J, Kosykh V, Darteil R, Hum DW, Fruchart JC, Staels B. Sirvent A, et al. Among authors: claudel t. FEBS Lett. 2004 May 21;566(1-3):173-7. doi: 10.1016/j.febslet.2004.04.026. FEBS Lett. 2004. PMID: 15147890 Free article.

7

The farnesoid X receptor: a novel drug target?

Claudel T, Sturm E, Kuipers F, Staels B. Claudel T, et al. Expert Opin Investig Drugs. 2004 Sep;13(9):1135-48. doi: 10.1517/13543784.13.9.1135. Expert Opin Investig Drugs. 2004. PMID: 15330745 Review.

8

The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.

Kuipers F, Claudel T, Sturm E, Staels B. Kuipers F, et al. Among authors: claudel t. Rev Endocr Metab Disord. 2004 Dec;5(4):319-26. doi: 10.1023/B:REMD.0000045103.00467.9a. Rev Endocr Metab Disord. 2004. PMID: 15486464 Review. No abstract available.

9

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.

Claudel T, Staels B, Kuipers F. Claudel T, et al. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2020-30. doi: 10.1161/01.ATV.0000178994.21828.a7. Epub 2005 Jul 21. Arterioscler Thromb Vasc Biol. 2005. PMID: 16037564 Review.

10

Plasma bile acids are not associated with energy metabolism in humans.

Brufau G, Bahr MJ, Staels B, Claudel T, Ockenga J, Böker KH, Murphy EJ, Prado K, Stellaard F, Manns MP, Kuipers F, Tietge UJ. Brufau G, et al. Among authors: claudel t. Nutr Metab (Lond). 2010 Sep 3;7:73. doi: 10.1186/1743-7075-7-73. Nutr Metab (Lond). 2010. PMID: 20815878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters